Investors / United States / Qiming Venture Partners USA
Qiming Venture Partners USA
Venture capital · Cambridge, MA, United States · North America
Qiming Venture Partners USA is the US-based venture team and fund launched in 2017 by China-based Qiming Venture Partners. It invests its financial and human capital in early-stage healthcare companies in the United States and Europe, offering access to the China market and the broader Qiming network.
Invests inMedia & EntertainmentEducationHealthcare & Biotech
In its own wordshealthcaretherapeuticsdigital healthbiotechearly stage
Your fit with Qiming Venture Partners USA
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsQiming Venture Partners USA lists 2 checked portfolio companies on its own site and is named in 2 funding rounds, 1 of them as lead. Its most frequent entry is Series A, 100% of the companies with a known first round. Its largest themes are Media & Entertainment (33%), Education (33%) and Healthcare & Biotech (33%). 50% of its companies are based in Canada. It invests most often alongside Benchstrength, Chugai Venture Fund and Creative Destruction Lab.
Counts come from funding rounds that name Qiming Venture Partners USA, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 100% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 1 | 1 |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Benchstrength | 1 |
| Chugai Venture Fund | 1 |
| Creative Destruction Lab | 1 |
| Debiopharm Innovation Fund | 1 |
| Fusion Fund | 1 |
| Innovation Endeavors | 1 |
| Lumira Ventures | 1 |
| SV Health Investors | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers2100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Media & Entertainment | 33% | 4% |
| Education | 33% | 7% |
| Healthcare & Biotech | 33% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare Qiming Venture Partners USA head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Qiming Venture Partners USA| Date | Company | Stage |
|---|---|---|
| 17 Sept 2026 | Series A Led | |
| 16 Sept 2025 | Series A |
Round details for Qiming Venture Partners USA
Amounts, full round histories and every co-investor in Qiming Venture Partners USA's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
2 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| The company's website appears to be a demonstration of a rich text editor. | Media & EntertainmentEducation | Sept 2026Series A | Funding round | |
| Dualitas Therapeutics develops bispecific antibody therapies for autoimmune, allergic, and other immune and inflammatory diseases. | Healthcare & Biotech | Sept 2025Series A | Funding round |
About this data
site last read 5 Nov 2026- Site
- qimingvcusa.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 16 Sept 2025
- Companies checked
- 2
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Qiming Venture Partners USA's profile as data
Pull Qiming Venture Partners USA's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/qimingvcusa.com
# also
GET /v1/firms/qimingvcusa.com/portfolio
GET /v1/firms/qimingvcusa.com/coinvestors
GET /v1/firms/qimingvcusa.com/news